Can you TOP this?! Zhong Yang Financial (TOP) traded at $6.70 two days ago; current price: $130!

Very tired of hearing how Alvarez is the #1 prospect in baseball! His audition for The Show has been very painful to watch for this Mets fan…

Nice catch on SKAS; that does sound a bit ominous...

especially considering the rapacious tax-and-spend regime calling the shots in NYC...

SKAS printing a new high on solid 2022 results; got any left?


https://www.otcmarkets.com/stock/SKAS/news/SAKER-AVIATION-SERVICES-INC-ANNOUNCES-FINANCIAL-RESULTS-FOR-THE-TWELVE-MONTHS-ENDED-DECEMBER-31-2022?id=396851

I'm adding some SPRS($2.90) today. While the quarter was somewhat disappointing, the PR was upbeat IMO. Also, we're talking about a company that's been profitable 20 out of the last 21 quarters...these guys can make money in all sorts of economic circumstances. Plus, $1.84/share in cash gives them significant firepower to buyback stock, initiate a dividend, or make an accretive acquisition...

Not to speak for SSK, but I would think it would a mathematical/accounting nightmare for him to figure out how much he made week-to-week on a SGOV position...

BDCO printing 5-year high @$2.90

Chairman Carroll added shares earlier this week...

ARTW($2.20) reports Q1 $.07 vs loss $.09, revenues up 41%


PR hasn't hit Dow Jones yet...

Bought some BDCO($2); 10K is filed $2.34 EPS

https://www.sec.gov/ix?doc=/Archives/edgar/data/793306/000165495423004195/bdco_10k.htm

PGNT($7.38) remains comically cheap; 2022 EPS $2.76; book value $8.88/share; cash/share $3.09


Operating income at PGNT has gone from $2.0M to $3.1M to $5.4M to $6.5M to $7.6M over the past five years.

2022 financials are linked here:

https://www.otcmarkets.com/otcapi/company/financial-report/362614/content

Chairman's 2022 shareholder letter is linked here:

https://img1.wsimg.com/blobby/go/02c2f6b2-128e-492a-a35d-9f22103bb8c5/downloads/2022%20Annual%20Letter.pdf?ver=1680118308435

I've added VASO @$.24; I liked this quote from the PR...looks like business remains strong...




"With a healthy financial position and a diversified business portfolio, management is optimistic about the Company's performance going forward. Our IT segment has improved operating efficiency as it's recovering from the impact of the COVID-19 pandemic; our professional sales service segment continues to outperform expectations and has expanded the scope of its partnership with GE HealthCare; and our equipment segment is starting to evolve from a pure product play to a more product-based service business."


https://www.otcmarkets.com/stock/VASO/news/CORRECTION-FROM-SOURCE-Vaso-Corporation-Announces-Financial-Results-for-Fourth-Quarter-and-Full-Year-of-2022?id=394902

AATV($.25) looks cheap; 2022 EPS $.07 vs $.01; revenues up 83% to $10.3M; book value $.355/share; cash/share $.19


P/E is less than 1, net of cash!


https://www.otcmarkets.com/otcapi/company/financial-report/362820/content

CUBI($10.30) crashing 55% to covid-lows; any redeeming value in this board-favorite black box? TIA

ZYXI sliding about $1.50/share AH on postponement of earnings...



Zynex, Inc. to Postpone Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call

PR Newswire

ENGLEWOOD, Colo., March 6, 2023

ENGLEWOOD, Colo., March 6, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will postpone the release of its fourth quarter and full year financial results and conference call initially scheduled for Monday, March 6, 2023 at 4:15 p.m. ET.

The company will announce its fourth quarter and full year 2022 financial results and conference call schedule in a future press release to allow additional time to complete its year-end closing procedures.

Don't you appreciate how patient he is with you and your trivial points?

SPRS($3.40) now trades at P/E 3, net of cash...


and that cash pile has been growing for years. Check out this trend in cash on the balance sheet over the past 6 FY year-ends: $1.1M, $1.8M, $2.7M, $4.4M, $6.5M, $8.7M.

Also, that backlog of $18.4M, while clearly down year-over-year, is by far the second largest in company history.

SPRS remains a no-brainer for me....

I didn't sell VASO. Got a link where I posted that, lol?

In SSK's current Pick 4 contest, I traded out of VASO into PYYX, thereby locking in a nice percentage gain on VASO and hoping to parlay that gain into further gains with PYYX. Given the short-term nature of the contest, this is a strategy for success.

I continue to hold all my VASO and agree with you that it should move higher still.

The larger issue is that you should not invest in microcaps at all as you do not have the temperament for it. Stick with triple-leveraged ETFs that trade millions of shares a day; I'll do the hard research needed to pick microcap winners...

Nice trade...lunch is on you :)

What's your cost on the LLAP shares?

Great trade on UUU($2.77) larry....congrats!

Alarming! UUU has traded 7+ million shares already!

As expected, SSY spiked to $1.47 on the PR a little while ago. I took my profit...

Thanks hweb. Are you playing the potential pop?

In SSY($1.19) for a trade; Q2 EPS $.29, revenues up 38% to $14.4M


as reported in today's 10-Q. Book value is about $2.60/share. Probably some funny money in there somewhere as the company is traditionally a money-loser. I'm expecting some low-float action when/if the numbers hit the tape...

ESOA($2.40) sliding 12% pre-market; special dividend last month was a crazy head-fake to shareholders with these Q1 results already in the books!

Thanks SSK

SSK, I'd appreciate your opinion on PPBN($19.90) when you get a chance...TIA



https://www.otcmarkets.com/stock/PPBN/news/Pinnacle-Bankshares-Corporation-Announces-Record-High-Fourth-Quarter-and-2022-Earnings?id=389070

Haven't seen that kind of action on a pink sheeter in a long, long time.


Wow...ain't that the truth!! Bring it on....

Up a cool 750% at the close !

I've followed ETCC for years. In fact I sold the last of my shares just a couple weeks ago for about $.25 (barf) when they reported disappointing Q3 results. This is a giant contract for them (~4x annual revenues) but, as hweb noted, very few details...especially the term of the contract!

I almost pounced when I saw the headline but, sadly, didn't pull the trigger...

ETCC($1.06) up 364% on $85M contract announcement! Hope they didn't forget a decimal point...


https://www.otcmarkets.com/stock/ETCC/news/ETCs-Aircrew-Training-Systems-Unit-Awarded-85-Million-Contract?id=388871

FRD($11.43) has added 25% since your post, now printing a new 52-week high! Not coincidentally, comp STLD has also had a great run...it printed an all-time high today...

SLRK($10.90) pre-tax income 2016-22: $0.9M,$1.7M,$2.9M,$4.6M,$7.7M,$14.7M,$22M


2022 EPS $4.25 vs $2.58 last year; tangible book value $13.43 at 12/31/22; P/E ratio now a microscopic 2.6


I added a few this morning...

Thanks SSK

SSK, I'd appreciate a TA read on VASO when you get a chance...TIA

In May 2010, VASO "was appointed by GEHC as its exclusive representative for the sale of select GE diagnostic imaging equipment to specific market segments in the 48 contiguous states of the United States and the District of Columbia. The original agreement ("GEHC Agreement") was for three years ending June 30, 2013; it has been extended several times with the current extension through December 31, 2026, subject to earlier termination under certain conditions."

Given that their contract with GEHC has been extended "several times", I'm confident that their relationship is very solid and investable. VASO's other units are currently money-losers, which is why I said that if the company got rid of them the stock would be that much more valuable. As it is, I view the GEHC contract as quite undervalued by the stock market...

I've been adding VASO around $.19. Major-customer GEHC (GE Healthcare) has been on a tear since the 1/3/23 spinout from GE, with the stock surging from $58 to $73 today. GEHC is printing new highs today after reporting 2022 results as a stand-alone company. The company gave a 2023 EPS forecast of $3.60-3.75, suggesting a forward P/E of about 20 on the shares.

GE HealthCare President and CEO Peter Arduini said, “GE HealthCare delivered strong revenue growth in the fourth quarter and full year 2022 driven by robust end market demand, improved pricing, and easing supply chain pressures. Revenue growth reflects our progress to offset delivery challenges and improve product fulfillment."

Arduini continued, "Looking ahead, we're confident that our accelerated investment in innovation, as well as standardization across platforms, will drive revenue and margin growth. We're seeing customers continue to invest along with macroeconomic tailwinds, such as increasing healthcare digitization, expanding access to care, and an aging population globally. We are well positioned to deliver on our 2023 commitments.”


VASO focuses specifically on marketing/servicing/training of GEHC diagnostic imaging equipment and it's noteworthy that in today's earnings PR GEHC cited "strong order growth in Imaging and Ultrasound" contributing to solid Q4'22 results. GEHC imaging revenues were up 18% in Q4'22 and 10% in 2022 (on an organic basis).


VASO's GEHC business (conducted through their Professional sales and service segment) accounts for all of the company's operating income, and is having a very impressive year with q1, q2, and q3 coming in at $237K, $2.75M, and $3.14M, respectively. As q4 is traditionally the company's strongest, the quarterly trends for 2022 look quite promising for a very strong q4 report in late March.

VASO shares currently trade at a P/E of less than 5. I believe the shares are quite undervalued given the company's relationship with GE Healthcare (recently extended through 2025) and strong cash flows. Cash on the balance sheet has moved from $5.8M to $15.9M to $18.7M over the last three quarters.

If the company ever wised up and jettisoned its other two money-losing units, the stock would really soar...

Condolences on CODA, gil. Anything of redeeming value come out of the CC? TIA

You know what's really "insane"?? That you post the same drivel, day after day, week after week, and you don't realize how it degrades the quality of the board.

Thanks for a nice summary of pros and cons, nelson